Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the Phase III MAJESTY study in adults with primary membranous nephropathy met its primary endpoint, showing ...

On top of 348 known job cuts across the organization last year, Roche’s Genentech division laid off an additional 141 ...

Under the agreement, SanegeneBio has granted Genentech exclusive worldwide rights to develop and commercialize the undisclosed program.

Genentech's CEO told the Business Times that a massive renovation set to begin in South San Francisco is meant to reimagine ...

WASHINGTON — Plenty of pharmaceutical executives have decried Democrats’ new drug pricing law as detrimental to the industry. But few are willing to say they may be willing to delay treatments for ...

The Philadelphia Department of Commerce awarded $450,000 in matching grants to local life sciences companies in January. The funds will match the amount companies have received from federal Small ...

The trial showed fenebrutinib reduced disability progression risk by 12% compared to Ocrevus, the only approved PPMS ...

The deal provides SanegeneBio with an upfront payment of $200m.

Genentech is honing in on an aspect of the patient community that is too often overlooked — the role of caregivers in managing rare diseases. In a recently-released short film, Genentech tells the ...

Biotechnology company Genentech is expanding its local manufacturing capabilities with a $450 million investment in its Oceanside campus. Genentech was founded in 1976 and has been considered a ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today new late-breaking data from the Phase III FENtrepid study showing the investigational Bruton’s tyrosine kinase (BTK ...

Following an extensive inspection, the Environmental Protection Agency fined Genentech more than $158,000 for hazardous waste violations at a facility in California, the latest instance in which a ...